bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析

◆英語タイトル:bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1636
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

bluebird bio Inc (BLUE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

bluebird bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaborations with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

bluebird bio Inc Key Recent Developments

Mar 26,2020 bluebird bio provides assessment of impact of COVID-19, update on business operations and clinical program development
Feb 18,2020 bluebird bio reports fourth quarter and full year 2019 financial results and highlights operational progress
Oct 31,2019 bluebird bio reports third quarter 2019 financial results and highlights operational progress
Oct 23,2019 bluebird bio announces transition of Chief Strategy Officer Jeffrey T. Walsh

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
bluebird bio Inc – Key Facts
bluebird bio Inc – Key Employees
bluebird bio Inc – Key Employee Biographies
bluebird bio Inc – Major Products and Services
bluebird bio Inc – History
bluebird bio Inc – Company Statement
bluebird bio Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
bluebird bio Inc – Business Description
bluebird bio Inc – Corporate Strategy
bluebird bio Inc – SWOT Analysis
SWOT Analysis – Overview
bluebird bio Inc – Strengths
bluebird bio Inc – Weaknesses
bluebird bio Inc – Opportunities
bluebird bio Inc – Threats
bluebird bio Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
bluebird bio Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 26, 2020: bluebird bio provides assessment of impact of COVID-19, update on business operations and clinical program development
Feb 18, 2020: bluebird bio reports fourth quarter and full year 2019 financial results and highlights operational progress
Oct 31, 2019: bluebird bio reports third quarter 2019 financial results and highlights operational progress
Oct 23, 2019: bluebird bio announces transition of Chief Strategy Officer Jeffrey T. Walsh
Oct 10, 2019: Novo Nordisk and bluebird bio to develop genetic disease therapies
Oct 09, 2019: bluebird bio and Novo Nordisk enter into research agreement to develop in vivo genome editing candidates for haemophilia and other severe genetic diseases
Sep 27, 2019: bluebird bio appoints William R. Sellers, M.D. to Board of Directors
Aug 01, 2019: bluebird bio reports second quarter 2019 financial results and highlights operational progress
May 09, 2019: bluebird bio’s Analyst Day Highlights Commercial Path to Patients and Research Engine Focused on Next-Generation Gene and Cell Therapies
May 02, 2019: bluebird bio reports first quarter 2019 financial results and highlights operational progress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
bluebird bio Inc, Key Facts
bluebird bio Inc, Key Employees
bluebird bio Inc, Key Employee Biographies
bluebird bio Inc, Major Products and Services
bluebird bio Inc, History
bluebird bio Inc, Other Locations
bluebird bio Inc, Subsidiaries
bluebird bio Inc, Key Competitors
bluebird bio Inc, Ratios based on current share price
bluebird bio Inc, Annual Ratios
bluebird bio Inc, Annual Ratios (Cont...1)
bluebird bio Inc, Interim Ratios
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
bluebird bio Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
bluebird bio Inc, Performance Chart (2015 - 2019)
bluebird bio Inc, Ratio Charts
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Raiffeisen Group:企業の戦略・SWOT・財務情報
    Raiffeisen Group - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bank Leumi le-Israel B.M.:戦略・SWOT・企業財務分析
    Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report Summary Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grenergy Renovables SL (GRE):電力:M&Aディール及び事業提携情報
    Summary Grenergy Renovables SL (Grenergy Renovables), a subsidiary of DARUAN Venture Capital SCR, is an alternative energy company that generates renewable energy through solar photovoltaic plants. The company provides services such as construction, engineering, and procurement services, project dev …
  • Energias de Portugal SA (EDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Mediaset S.p.A. (MS):企業の財務・戦略的SWOT分析
    Mediaset S.p.A. (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company offers banking, insurance companies, public institutions, healthcare, telecommunication, utilities, ERP solutions, IT infrastructure and others. Its IT infrastructure solutions include …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務分析
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fosun International Ltd (656):製薬・医療:M&Aディール及び事業提携情報
    Summary Fosun International Ltd (Fosun) is an investment holding company, which offers asset management, insurance, industrial operations and strategic investment services. The company, through its subsidiaries, manufactures and sells pharmaceutical and healthcare products; undertakes property devel …
  • AltaGas Ltd.:企業の戦略・SWOT・財務情報
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務情報
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • Pyxus International Inc:企業の戦略・SWOT・財務情報
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sika AG (SIKA):企業の財務・戦略的SWOT分析
    Sika AG (SIKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • PG&E Corporation (PCG):企業の財務・戦略的SWOT分析
    PG&E Corporation (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • American International Group Inc:企業のM&A・事業提携・投資動向
    American International Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American International Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Natco Pharma Ltd (NATCOPHARM):企業の財務・戦略的SWOT分析
    Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆